Last reviewed · How we verify
NCT07350486: LLM-CoManage
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia
NA trial testing LLM-Enabled Clinician-Patient Co-management in Hypertension in 6,000 participants. Not yet recruiting.
30 June 2027
Quick facts
| Lead sponsor | First Hospital of China Medical University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 6,000 |
| Start date | 15 June 2026 |
| Primary completion | 30 June 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- LLM-Enabled Clinician-Patient Co-management
Conditions studied
- Hypertension — all drugs for Hypertension →
- Diabetes — all drugs for Diabetes →
- Dyslipidemia — all drugs for Dyslipidemia →
Sponsor
First Hospital of China Medical University
Who can join
40 and older, any sex, with Hypertension or Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effectiveness of a large language model (LLM)-supported, community-based integrated management model in improving cardiometabolic multimorbidity control among adults with hypertension and coexisting diabetes or dyslipidemia. Adopting an interventional study design, eligible patients will be recruited to compare the disease control indicators between LLM-assisted management and conventional management, so as to verify the effectiveness and safety of the former.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07350486
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other First Hospital of China Medical University trials
Trials by the same sponsor.
- NCT07534865 — Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts · NA · recruiting
- NCT07476898 — Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window · Phase 3 · not yet recruiting
- NCT07319065 — Left Ventricular Myocardial Work for Predicting Response to CRT · not yet recruiting
- NCT07286812 — Digital Technology Combined With Blood Marker Screening and Diagnosis for Community Populations Based on Classification · not yet recruiting
- NCT07271992 — TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in E · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07350486 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First Hospital of China Medical University
- Last refreshed: 20 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07350486.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing